Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database
Journal of Hepatocellular Carcinoma · 2026-09 · Volume 13 · 1-15
DOI: 10.2147/jhc.s625029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-09. Verfasst von Woo-Hyoung Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
A simplified prognostic model, the AFP-PIVKA-II (AP) score, was developed to predict outcomes after resection of hepatocellular carcinoma (HCC). Unlike the conventional ADV score, it relies only on serum biomarkers (AFP and PIVKA-II), excluding tumor size.
Methods
This study included 2257 patients who underwent liver resection for HCC, using data from the Korea Liver Cancer Registry (2015-2022). The AP score's ability to predict overall survival (OS) and microvascular invasion (MVI) was evaluated and compared with radiologic and pathologic ADV scores.
Results
Median preoperative AFP and PIVKA-II levels were 9.2 ng/mL and 62 mAU/mL. Increasing AP scores showed consistent association with worse OS (p < 0.001). Kaplan-Meier survival analyses using 1.0 log-, 2.0 log-, and 4.0 log-interval groupings consistently demonstrated a stepwise decline in OS with increasing AP score (all p < 0.001). At 4.0 log intervals, Harrell's c-indices for OS prediction were 0.604 (AP score), 0.681 (radiologic ADV score), and 0.677 (pathologic ADV score). For MVI prediction, the areas under the ROC curve values were 0.705, 0.733, and 0.741, respectively. Although ADV score-based models performed better overall, the AP score showed acceptable predictive ability for post-resection patient survival.
Conclusion
The AP score is a simple, biomarker-based tool for estimating survival after HCC resection. While less accurate than ADV score models, its convenience supports use in settings requiring rapid assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Korean Liver Cancer Association, Seoul, Korea.
ORCID-Profile: Woo-Hyoung Kang, Shin Hwang, I-Ji Jeong, Deok-Bog Moon, Dong-Hwan Jung, Gi-Won Song, Young-In Yoon, Tae-Yong Ha, Gil-Chun Park
Zitieren
APA
Kang, W. H., Hwang, S., Jeong, I. J., Moon, D. B., Jung, D. H., Song, G. W., Yoon, Y. I., Ha, T. Y., & Park, G. C. (2026). Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database. Journal of Hepatocellular Carcinoma, Volume 13, 1-15. https://doi.org/10.2147/jhc.s625029
Vancouver
Kang WH, Hwang S, Jeong IJ, Moon DB, Jung DH, Song GW, et al. Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-15. doi:10.2147/jhc.s625029
BibTeX
@article{Kang2026,
author = {Kang, Woo-Hyoung and Hwang, Shin and Jeong, I-Ji and Moon, Deok-Bog and Jung, Dong-Hwan and Song, Gi-Won and Yoon, Young-In and Ha, Tae-Yong and Park, Gil-Chun},
title = {Prediction of Post-Resection Prognosis of HCC According to AFP-PIVKA-II (AP) Score as a Simplified Biomarker of ADV Score: A Validation Analysis Using Korea Liver Cancer Registry Database},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--15},
doi = {10.2147/jhc.s625029}
}
EUVIMED